Medicines and Healthcare products Regulatory Agency
Certificate of GMP Compliance Of A Manufacturer(1),(2)
Regulation 5 of the current Veterinary Medicines Regulations
The competent authority of United Kingdom confirms the following :Has been inspected in connection with marketing authorisation(s) listing manufacturers located outside of the European Economic Area in accordance with Regulation 5 of The current Veterinary Medicines Regulations
From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on 16/05/2016, it is considered that it complies with
- The principles and guidelines of Good Manufacturing Practice laid down in Regulation 5 of the current Veterinary Medicines Regulations
This certificate reflects the status of the manufacturing site at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than three years have elapsed since the date of that inspection. However, this period of validity may be reduced or extended using regulatory risk management principles by an entry in the Restrictions or Clarifying remarks field. This certificate is valid only when presented with all pages and both Parts 1 and 2. The authenticity of this certificate may be verified in MHRA-GMDP. If it does not appear, please contact the issuing authority.
- (1) Guidance on the interpretation of this template can be found in the Help menu of MHRA-GMDP database.
- (2) These requirements fulfil the GMP recommendations of WHO.
1. MANUFACTURING OPERATIONS |
[ 1.1 ] Sterile Products |
[ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
[ 1.1.1.2 ] Lyophilisates |
[ 1.1.1.4 ] Small volume liquids |
[ 1.1.2 ] Terminally Sterilised (processing operations for the following dosage forms) |
[ 1.1.2.2 ] Semi-solids |
[ 1.1.2.3 ] Small volume liquids |
[ 1.2 ] Non-sterile products |
[ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) |
[ 1.2.1.5 ] Liquids for external use |
[ 1.2.1.6 ] Liquids for internal use |
[ 1.2.1.11 ] Semi-solids |
[ 1.2.1.12 ] Suppositories |
[ 1.2.1.17 ] Other non-sterile medicinal productsSuspensions, Nasal Sprays sprays (pump liquid type not metered dose inhalers which are pressurised) |
[ 1.3 ] Biological medicinal products |
[ 1.3.1 ] Biological medicinal products |
[ 1.3.1.2 ] Immunological products |
[ 1.3.1.8 ] Other biological medicinal productsImmunoglobulin derived from horse serum both as a bulk API lyophilised and is then making the finish |
[ 1.4 ] Other products or manufacturing activity |
[ 1.4.2 ] Sterilisation of active substances/excipients/finished products: |
[ 1.4.2.1 ] Filtration |
[ 1.4.2.2 ] Dry heat |
[ 1.4.2.3 ] Moist heat |
[ 1.4.3 ] OtherSuper critical fluid carbon dioxide sterilisation |
[ 1.5 ] Packaging |
[ 1.5.2 ] Secondary packaging |
[ 1.6 ] Quality control testing |
[ 1.6.1 ] Microbiological: sterility |
[ 1.6.2 ] Microbiological: non-sterility |
[ 1.6.3 ] Chemical/Physical |
[ 1.6.4 ] Biological |
Any restrictions related to the scope of this certificate:
Building | Room | Line/equipment | QC Testing | Products |
---|---|---|---|---|
B41 - Note The Pfizer Kalamazoo legal entity name is: Pharmacia and Upjohn Company, LLC | Physical, chemical, biological, microbiology - sterile and non sterile | ATGAM Biological pre-approval inspection |
07/12/2016 | Name and signature of the authorised person of the Competent Authority of United Kingdom |
Confidential | |
Medicines and Healthcare products Regulatory Agency | |
Tel : Confidential |